Table for the 451 triples with object <http://purl.obolibrary.org/obo/PR_000006121> sorted by label

SubjectPredicate
?:9-hydroxyrisperidone_inhibition_constant_cyp2d6?:value
?:N-demethyldesacetyl-diltiazem?:primary_total_clearance_enzyme
?:N-demethyldesacetyl-diltiazem?:substrate_of
?:N-demethyldesacetyl-diltiazem_is_not_substrate_of_cyp2d6?:value
?:N-demethyldesacetyl-diltiazem_primary_total_clearance_enzyme_cyp2d6?:value
?:N-demethyldesacetyl-diltiazem_substrate_of_cyp2d6?:value
?:N-desalkylquetiapine?:does_not_inhibit
?:N-desalkylquetiapine_does_not_inhibit_cyp2d6?:value
?:N-desalkylquetiapine_inhibits_cyp2d6?:value
?:R-citalopram?:does_not_inhibit
?:R-citalopram?:substrate_of
?:R-citalopram_does_not_inhibit_cyp2d6?:value
?:R-citalopram_inhibits_cyp2d6?:value
?:R-citalopram_is_not_substrate_of_cyp2d6?:value
?:R-citalopram_substrate_of_cyp2d6?:value
?:R-demethylcitalopram?:substrate_of
?:R-demethylcitalopram_is_not_substrate_of_cyp2d6?:value
?:R-demethylcitalopram_substrate_of_cyp2d6?:value
?:R-didemethylcitalopram?:does_not_inhibit
?:R-didemethylcitalopram_does_not_inhibit_cyp2d6?:value
?:R-didemethylcitalopram_inhibits_cyp2d6?:value
?:S-demethylcitalopram?:substrate_of
?:S-demethylcitalopram_is_not_substrate_of_cyp2d6?:value
?:S-demethylcitalopram_substrate_of_cyp2d6?:value
?:S-didemethylcitalopram?:does_not_inhibit
?:S-didemethylcitalopram_does_not_inhibit_cyp2d6?:value
?:S-didemethylcitalopram_inhibits_cyp2d6?:value
?:amiodarone?:inhibits
?:amiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:amiodarone_does_not_inhibit_cyp2d6?:value
?:amiodarone_inhibits_cyp2d6?:value
?:aripiprazole?:does_not_inhibit
?:aripiprazole?:substrate_of
?:aripiprazole_does_not_inhibit_cyp2d6?:value
?:aripiprazole_inhibits_cyp2d6?:value
?:aripiprazole_is_not_substrate_of_cyp2d6?:value
?:aripiprazole_substrate_of_cyp2d6?:value
?:asenapine?:is_not_substrate_of
?:asenapine_is_not_substrate_of_cyp2d6?:value
?:asenapine_substrate_of_cyp2d6?:value
?:atazanavir?:does_not_inhibit
?:atazanavir_does_not_inhibit_cyp2d6?:value
?:atazanavir_inhibits_cyp2d6?:value
?:atomoxetine?:does_not_inhibit
?:atomoxetine?:primary_total_clearance_enzyme
?:atomoxetine_does_not_inhibit_cyp2d6?:value
?:atomoxetine_inhibits_cyp2d6?:value
?:atomoxetine_primary_total_clearance_enzyme_cyp2d6?:value
?:atorvastatin_is_not_substrate_of_cyp2d6?:value
?:atorvastatin_substrate_of_cyp2d6?:value
?:bufuralol?:in_vitro_probe_substrate_of_enzyme
?:bufuralol_in_vitro_probe_substrate_of_enzyme_cyp2d6?:value
?:bupropion?:inhibits
?:bupropion is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:bupropion_does_not_inhibit_cyp2d6?:value
?:bupropion_inhibits_cyp2d6?:value
?:celecoxib?:inhibits
?:celecoxib_does_not_inhibit_cyp2d6?:value
?:celecoxib_inhibits_cyp2d6?:value
?:cinacalcet?:inhibits
?:cinacalcet?:substrate_of
?:cinacalcet is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:cinacalcet_does_not_inhibit_cyp2d6?:value
?:cinacalcet_inhibits_cyp2d6?:value
?:cinacalcet_is_not_substrate_of_cyp2d6?:value
?:cinacalcet_substrate_of_cyp2d6?:value
?:citalopram_inhibits_cyp2d6?:value
?:citalopram_substrate_of_cyp2d6?:value
?:clarithromycin?:is_not_substrate_of
?:clarithromycin_is_not_substrate_of_cyp2d6?:value
?:clarithromycin_substrate_of_cyp2d6?:value
?:clozapine?:substrate_of
?:clozapine-N-oxide?:is_not_substrate_of
?:clozapine-N-oxide_is_not_substrate_of_cyp2d6?:value
?:clozapine-N-oxide_substrate_of_cyp2d6?:value
?:clozapine_inhibition_constant_cyp2d6?:value
?:clozapine_is_not_substrate_of_cyp2d6?:value
?:clozapine_substrate_of_cyp2d6?:value
?:cyp2d6_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine?:object
?:cyp2d6_controls_formation_of_4-hydroxyatomoxetine?:object
?:cyp2d6_controls_formation_of_4-hydroxydebrisoquine?:object
?:cyp2d6_controls_formation_of_9-hydroxyrisperidone?:object
?:cyp2d6_controls_formation_of_N-dealkylperphenazine?:object
?:cyp2d6_controls_formation_of_O-desmethylvenlafaxine?:object
?:cyp2d6_controls_formation_of_clozapine-N-oxide?:object
?:cyp2d6_controls_formation_of_desmethylclozapine?:object
?:cyp2d6_controls_formation_of_hydroxybupropion?:object
?:cyp2d6_controls_formation_of_threohydrobupropion?:object
?:cyp2d6_polymorphic_enzyme_True?:object
?:debrisoquine?:in_viVo_probe_substrate_of_enzyme
?:debrisoquine?:in_vitro_probe_substrate_of_enzyme
?:debrisoquine_in_viVo_probe_substrate_of_enzyme_cyp2d6?:value
?:debrisoquine_in_vitro_probe_substrate_of_enzyme_cyp2d6?:value
?:demethylcitalopram_substrate_of_cyp2d6?:value
?:desacetyldiltiazem?:primary_total_clearance_enzyme
?:desacetyldiltiazem?:substrate_of
?:desacetyldiltiazem_is_not_substrate_of_cyp2d6?:value
?:desacetyldiltiazem_primary_total_clearance_enzyme_cyp2d6?:value
?:desacetyldiltiazem_substrate_of_cyp2d6?:value
?:desipramine?:primary_total_clearance_enzyme
?:desipramine_primary_total_clearance_enzyme_cyp2d6?:value
?:desvenlafaxine?:is_not_substrate_of
?:desvenlafaxine_is_not_substrate_of_cyp2d6?:value
?:desvenlafaxine_substrate_of_cyp2d6?:value
?:dextromethorphan?:in_viVo_probe_substrate_of_enzyme
?:dextromethorphan?:in_vitro_probe_substrate_of_enzyme
?:dextromethorphan?:primary_total_clearance_enzyme
?:dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d6?:value
?:dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d6?:value
?:dextromethorphan_primary_total_clearance_enzyme_cyp2d6?:value
?:didemethylcitalopram_inhibits_cyp2d6?:value
?:diltiazem_primary_metabolic_clearance_enzyme_cyp2d6?:value
?:duloxetine?:inhibits
?:duloxetine?:substrate_of
?:duloxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:duloxetine_does_not_inhibit_cyp2d6?:value
?:duloxetine_inhibits_cyp2d6?:value
?:duloxetine_is_not_substrate_of_cyp2d6?:value
?:duloxetine_substrate_of_cyp2d6?:value
?:escitalopram?:substrate_of
?:escitalopram_does_not_inhibit_cyp2d6?:value
?:escitalopram_inhibits_cyp2d6?:value
?:escitalopram_is_not_substrate_of_cyp2d6?:value
?:escitalopram_substrate_of_cyp2d6?:value
?:eszopiclone?:does_not_inhibit
?:eszopiclone_does_not_inhibit_CYP2D6?:value
?:eszopiclone_inhibits_CYP2D6?:value
?:fluoxetine?:inhibits
?:fluoxetine?:substrate_of
?:fluoxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:fluoxetine_does_not_inhibit_cyp2d6?:value
?:fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:value
?:fluoxetine_inhibits_cyp2d6?:value
?:fluoxetine_is_not_substrate_of_cyp2d6?:value
?:fluoxetine_permanently_deactivates_catalytic_function_cyp2d6?:value
?:fluoxetine_substrate_of_cyp2d6?:value
?:fluphenazine_inhibition_constant_cyp2d6?:value
?:fluvoxamine?:substrate_of
?:fluvoxamine_is_not_substrate_of_cyp2d6?:value
?:fluvoxamine_substrate_of_cyp2d6?:value
?:haloperidol_inhibition_constant_cyp2d6?:value
?:iloperidone?:inhibits
?:iloperidone?:substrate_of
?:iloperidone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:iloperidone_does_not_inhibit_cyp2d6?:value
?:iloperidone_inhibits_cyp2d6?:value
?:iloperidone_is_not_substrate_of_cyp2d6?:value
?:iloperidone_substrate_of_cyp2d6?:value
?:lansoprazole?:does_not_inhibit
?:lansoprazole_does_not_inhibit_cyp2d6?:value
?:lansoprazole_inhibits_cyp2d6?:value
?:metoprolol_in_viVo_probe_substrate_of_enzyme_cyp2d6?:value
?:mirtazapine?:does_not_inhibit
?:mirtazapine?:substrate_of
?:mirtazapine_does_not_inhibit_cyp2d6?:value
?:mirtazapine_inhibits_cyp2d6?:value
?:mirtazapine_is_not_substrate_of_cyp2d6?:value
?:mirtazapine_substrate_of_cyp2d6?:value
?:montelukast?:does_not_inhibit
?:montelukast_does_not_inhibit_cyp2d6?:value
?:montelukast_inhibits_cyp2d6?:value
?:nefazodone?:is_not_substrate_of
?:nefazodone_is_not_substrate_of_cyp2d6?:value
?:nefazodone_substrate_of_cyp2d6?:value
?:olanzapine?:substrate_of
?:olanzapine_is_not_substrate_of_cyp2d6?:value
?:olanzapine_substrate_of_cyp2d6?:value
?:omeprazole?:does_not_inhibit
?:omeprazole_does_not_inhibit_cyp2d6?:value
?:omeprazole_inhibits_cyp2d6?:value
?:paliperidone?:does_not_inhibit
?:paliperidone_does_not_inhibit_cyp2d6?:value
?:paliperidone_inhibition_constant_cyp2d6?:value
?:paliperidone_inhibits_cyp2d6?:value
?:pantoprazole?:does_not_inhibit
?:pantoprazole_does_not_inhibit_cyp2d6?:value
?:pantoprazole_inhibits_cyp2d6?:value
?:paroxetine?:inhibits
?:paroxetine?:substrate_of
?:paroxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:paroxetine_does_not_inhibit_cyp2d6?:value
?:paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:value
?:paroxetine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6?:value
?:paroxetine_inhibits_cyp2d6?:value
?:paroxetine_is_not_substrate_of_cyp2d6?:value
?:paroxetine_permanently_deactivates_catalytic_function_cyp2d6?:value
?:paroxetine_substrate_of_cyp2d6?:value
?:perphenazine?:substrate_of
?:perphenazine_inhibition_constant_cyp2d6?:value
?:perphenazine_is_not_substrate_of_cyp2d6?:value
?:perphenazine_substrate_of_cyp2d6?:value
?:quetiapine?:does_not_inhibit
?:quetiapine_does_not_inhibit_cyp2d6?:value
?:quetiapine_inhibits_cyp2d6?:value
?:quinidine?:inhibits
?:quinidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:quinidine_does_not_inhibit_cyp2d6?:value
?:quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:value
?:quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6?:value
?:quinidine_inhibits_cyp2d6?:value
?:quinidine_permanently_deactivates_catalytic_function_cyp2d6?:value
?:ranolazine?:inhibits
?:ranolazine?:substrate_of
?:ranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:ranolazine_does_not_inhibit_cyp2d6?:value
?:ranolazine_inhibits_cyp2d6?:value
?:ranolazine_is_not_substrate_of_cyp2d6?:value
?:ranolazine_substrate_of_cyp2d6?:value
?:risperidone?:primary_metabolic_clearance_enzyme
?:risperidone?:substrate_of
?:risperidone_inhibition_constant_cyp2d6?:value
?:risperidone_is_not_substrate_of_cyp2d6?:value
?:risperidone_primary_metabolic_clearance_enzyme_cyp2d6?:value
?:risperidone_substrate_of_cyp2d6?:value
?:ritonavir?:inhibits
?:ritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:ritonavir_does_not_inhibit_cyp2d6?:value
?:ritonavir_inhibits_cyp2d6?:value
?:rosiglitazone?:does_not_inhibit
?:rosiglitazone_does_not_inhibit_cyp2d6?:value
?:rosiglitazone_inhibits_cyp2d6?:value
?:sertraline?:inhibits
?:sertraline is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:sertraline_does_not_inhibit_cyp2d6?:value
?:sertraline_inhibits_cyp2d6?:value
?:sparteine_in_viVo_probe_substrate_of_enzyme_cyp2d6?:value
?:tamoxifen?:substrate_of
?:tamoxifen_is_not_substrate_of_cyp2d6?:value
?:tamoxifen_substrate_of_cyp2d6?:value
?:terbinafine?:inhibits
?:terbinafine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6?:EnzymeInhibited
?:terbinafine_does_not_inhibit_cyp2d6?:value
?:terbinafine_inhibits_cyp2d6?:value
?:thioridazine?:primary_total_clearance_enzyme
?:thioridazine?:substrate_of
?:thioridazine_inhibition_constant_cyp2d6?:value
?:thioridazine_is_not_substrate_of_cyp2d6?:value
?:thioridazine_primary_total_clearance_enzyme_cyp2d6?:value
?:thioridazine_substrate_of_cyp2d6?:value
?:thiothixene_inhibition_constant_cyp2d6?:value
?:topiramate?:does_not_inhibit
?:topiramate_does_not_inhibit_cyp2d6?:value
?:topiramate_inhibits_cyp2d6?:value
?:venlafaxine?:inhibits
?:venlafaxine?:primary_total_clearance_enzyme
?:venlafaxine?:substrate_of
?:venlafaxine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6?:EnzymeInhibited
?:venlafaxine_does_not_inhibit_cyp2d6?:value
?:venlafaxine_inhibits_cyp2d6?:value
?:venlafaxine_is_not_substrate_of_cyp2d6?:value
?:venlafaxine_primary_total_clearance_enzyme_cyp2d6?:value
?:venlafaxine_substrate_of_cyp2d6?:value
?:zaleplon?:is_not_substrate_of
?:zaleplon_is_not_substrate_of_cyp2d6?:value
?:zaleplon_substrate_of_cyp2d6?:value
?:ziprasidone?:does_not_inhibit
?:ziprasidone_does_not_inhibit_cyp2d6?:value
?:ziprasidone_inhibition_constant_cyp2d6?:value
?:ziprasidone_inhibits_cyp2d6?:value
?:ziprasidone_is_not_substrate_of_cyp2d6?:value
?:ziprasidone_substrate_of_cyp2d6?:value